Anti-PD-1 Therapy in Advanced Pediatric Malignancies in Nationwide Study: Good Outcome in Skin Melanoma and Hodgkin Lymphoma.

MLA

Marjańska, Agata, et al. “Anti-PD-1 Therapy in Advanced Pediatric Malignancies in Nationwide Study: Good Outcome in Skin Melanoma and Hodgkin Lymphoma.” Cancers, vol. 16, no. 5, Mar. 2024, p. 968. EBSCOhost, https://doi.org/10.3390/cancers16050968.

APA

Marjańska, A., Pawińska-Wąsikowska, K., Wieczorek, A., Drogosiewicz, M., Dembowska-Bagińska, B., Bobeff, K., Młynarski, W., Adamczewska-Wawrzynowicz, K., Wachowiak, J., Krawczyk, M. A., Irga-Jaworska, N., Węcławek-Tompol, J., Kałwak, K., Sawicka-Żukowska, M., Krawczuk-Rybak, M., Raciborska, A., Mizia-Malarz, A., Sobocińska-Mirska, A., Łaguna, P., & Balwierz, W. (2024). Anti-PD-1 Therapy in Advanced Pediatric Malignancies in Nationwide Study: Good Outcome in Skin Melanoma and Hodgkin Lymphoma. Cancers, 16(5), 968. https://doi.org/10.3390/cancers16050968

Chicago

Marjańska, Agata, Katarzyna Pawińska-Wąsikowska, Aleksandra Wieczorek, Monika Drogosiewicz, Bożenna Dembowska-Bagińska, Katarzyna Bobeff, Wojciech Młynarski, et al. 2024. “Anti-PD-1 Therapy in Advanced Pediatric Malignancies in Nationwide Study: Good Outcome in Skin Melanoma and Hodgkin Lymphoma.” Cancers 16 (5): 968. doi:10.3390/cancers16050968.